ENDPOINTS

BeiGene gets key win in patent spat over Brukinsa

A tribunal within the US Patent and Trademark Office invalidated several claims of a patent held by AbbVie’s Pharmacyclics, marking a key win for its rival BeiGene. The tribunal's ruling is a step forward for ...

Apr 30, 2025 - 20:43
 0
BeiGene gets key win in patent spat over Brukinsa
A tribunal within the US Patent and Trademark Office invalidated several claims of a patent held by AbbVie’s Pharmacyclics, marking a key win for its rival BeiGene. The tribunal's ruling is a step forward for ...
Read More

Tags:

Previous Article

¿Qué es una caminata espacial? (Grados 5.o a 8.o)

Next Article

The Geopolitics Of Critical Minerals: China’s Grip & The West’s Response

Related Posts

Roche promises $50B investment in the US as pharma tariffs inch closer

Roche promises $50B investment in the US as pharma tari...

Apr 22, 2025  0

European regulators recommend new drugs from Vertex, Amgen and Jazz 

European regulators recommend new drugs from Vertex, Am...

Apr 28, 2025  0

Caribou lays off 32% of staff, cuts lupus program

Caribou lays off 32% of staff, cuts lupus program

Apr 24, 2025  0